​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​

​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​

Infectious Disease Prevention and Health Services Bureau (IDPHSB)

​​

Hot Topics
​​​We’re monitoring the recent Bicillin® recall and its impact on providers and patients in Maryland. This page will be updated with the latest guidance and resources.

Check back often for new information.​
​​
Bicillin Recall Updates: 
​

Priority Actions Following​ Recall

CDC: Syphilis ​Treatment Guidelines

Recommendations for ​managing Bicillin shortages

Supply Updates: 

  • (2/19/2026) - Providers should use this Me​dical Request Form to request Bicillin for pregnant and other priority clients, as the medication remains available but is currently in limited supply and must be obtained through this request process.

  • (3/10/2026) - CDC has learned that the U.S. Food and Drug Administration (FDA) is allowing the temporary importation of Le​ntocilin© due to the ongoing limited availability and extended recove​ry of Bicillin® L-A (Penicillin G Benzathine Injectable Suspension, produced by King Pharmaceuticals LLC, a subsidiary of Pfizer). The National Network of STD Prevention Training Centers has posted infor​mation for health care providers on the administration of Lentocilin©.
​​

Technical Assistance


Webinars

Wednesday, May 6, 2026, at 3:00 PM ET​: ​

Bicillin​ L-A ​Sho​rtage: Implementing Lentocilin, What Clinicians Need to Know.​ Register here



Who We Are

The Infectious Disease Prevention & Health Services Bureau (IDPHSB​) is Maryland's response to sexually transmitted infections, including but not limited to HIV and viral hepatitis. IDPHSB works with local health departments and community organizations to meet the sexual health needs of all Marylanders.​​​



Ways to Partner

​​